Home / Stocks / DHR

Danaher (DHR, Life Sciences Tools & Services) Stock Valuation & Fair Value Significantly overvalued

Danaher (DHR, Life Sciences Tools & Services) trades at a blended P/E of 26.1, about 22% above its historical normal valuation, with a forward growth estimate of 9.0% and a PEG of 2.91. Analysts' one-year estimates have been hit 64% of the time.

DATA AS OF 2026-08-21
Blended P/E
26.1
Normal P/E
21.4
PEG
2.91
Fwd growth
9.0%
Div yield
0.7%
RSI (14)
51.7
Neutral

Valuation flags

Verdict history

tickerseer's rating moved from trading above fair value (2026-06-03) to significantly overvalued (2026-08-21).

Price and rating by weekClose moved +13.9 percent from 2026-06-03 to 2026-08-17, with 3 rating changes over 21 recorded weeks.2026-06-03: Trading above fair value, close 177.71 (recalculated)2026-06-10: Trading above fair value, close 183.25 (recalculated)2026-06-14: Trading above fair value, close 179.73 (recalculated)2026-06-16: Trading above fair value, close 180.97 (recalculated)2026-06-21: Trading above fair value, close 176.80 (recalculated)2026-07-02: Trading above fair value, close 197.93 (recalculated)2026-07-06: Trading above fair value, close 193.62 (recalculated)2026-07-09: Trading above fair value, close 195.98 (recalculated)2026-07-12: Significantly overvalued, close 199.05 (recalculated)2026-07-13: Significantly overvalued, close 200.16 (recalculated)2026-07-14: Significantly overvalued, close 199.05 (recalculated)2026-07-20: Significantly overvalued, close 201.11 (recalculated)2026-07-22: Significantly overvalued, close 179.14 (recalculated)2026-07-25: Trading above fair value, close 191.50 (recalculated)2026-07-27: Trading above fair value, close 196.50 (recalculated)2026-07-31: Trading above fair value, close 194.98 (recalculated)2026-08-03: Trading above fair value, close 194.982026-08-07: Trading above fair value, close 204.76 (recalculated)2026-08-10: Significantly overvalued, close 204.762026-08-14: Significantly overvalued, close 202.45 (recalculated)2026-08-17: Significantly overvalued, close 202.451782022026-06-032026-08-17
Attractively valuedFairly valuedAbove fair valueLarger dot: a stronger reading

Not every point was recorded live. Points marked recalculated apply today's valuation rules to the metrics tickerseer archived that week.

2026-06-03P/E 22.4+4%Trading above fair value
2026-06-10P/E 22.8+6%Trading above fair value
2026-06-14P/E 22.8+6%Trading above fair value
2026-06-16P/E 22.8+6%Trading above fair value
2026-06-21P/E 22.8+6%Trading above fair value
2026-07-02P/E 23.9+11%Trading above fair value
2026-07-06P/E 24.4+14%Trading above fair value
2026-07-09P/E 24.4+14%Trading above fair value
2026-07-12P/E 24.4+14%Significantly overvalued
2026-07-13P/E 24.4+14%Significantly overvalued
2026-07-14P/E 24.4+14%Significantly overvalued
2026-07-20P/E 25.0+17%Significantly overvalued
2026-07-22P/E 25.0+17%Significantly overvalued
2026-07-25P/E 23.4+9%Trading above fair value
2026-07-27P/E 23.4+9%Trading above fair value
2026-07-31P/E 23.9+11%Trading above fair value
2026-08-03P/E 23.8+11%Trading above fair value
2026-08-07P/E 24.3+13%Trading above fair value
2026-08-10P/E 24.9+16%Significantly overvalued
2026-08-14P/E 24.7+15%Significantly overvalued
2026-08-17P/E 24.6+15%Significantly overvalued
2026-08-21P/E 26.1+22%Significantly overvalued ← now

Frequently asked questions

Is Danaher stock overvalued?

At a blended P/E of 26.1 versus its historical normal P/E of 21.4, Danaher trades about 22% above its typical valuation, with a PEG of 2.91 on 9.0% forward growth. tickerseer currently rates it significantly overvalued.

What is Danaher's fair value and PEG?

Danaher trades at a blended P/E of 26.1 against a historical normal P/E of 21.4, a PEG of 2.91, and a forward growth estimate of 9.0%.

Has tickerseer's rating of Danaher changed?

tickerseer's rating moved from trading above fair value (2026-06-03) to significantly overvalued (2026-08-21).

Industry: Life Sciences Tools & Services. Create a free account to see the full analysis: the SeerAI score, its five quality sub-scores, valuation history, and the AI research note. Options setups and metric history are part of the paid plans.

See the full analysis →🔔 Track DHR free: valuation & earnings alerts

Get the free weekly earnings preview

One email each Monday with the week's named earnings setups, the reasoning, and what settled last week. Strikes and sizing stay in Premium.

It's free, and you can unsubscribe any time. Educational content, not investment advice.